NewsSource: EClinCloud official website archive

EClinCloud Launches Industry-Leading Clinical Trial Management System (CTMS)

3 min readEClinCloud Editorial Team
Cover image for the archived article on EClinCloud's launch of its industry-leading Clinical Trial Management System (CTMS)

EClinCloud announced the launch of the first application on its clinical research cloud platform, its Clinical Trial Management System (CTMS), to help customers address operational pain points in clinical operations. Through NNIT's specialized system validation services, the system ensures that EClinCloud's CTMS meets the stringent compliance requirements of applicable regulations.

Against the backdrop of the global pandemic, the biopharmaceutical industry has gained unprecedented prominence. With strict requirements placed on clinical trials by regulatory authorities around the world, sponsors are placing increasing emphasis on clinical trial process management and data quality improvement. How to improve management efficiency in new drug R&D, better integrate resources, and ensure clinical research compliance has become a central focus across the industry. Against this backdrop, EClinCloud's CTMS was created.

EClinCloud's CTMS provides a comprehensive set of capabilities, including modules for milestone tracking, trial participant enrollment management, regulatory approval management, monitoring visits, protocol deviations, and safety reporting. With clear, concise reports, the system gives project management teams at-a-glance visibility into study status while offering intuitive operation and streamlined workflows. It supports zero-code flexible configuration, incorporates industry best practices, and accommodates tailored customization. EClinCloud's CTMS enables rapid deployment, saving more than 60% of the time compared with traditional CTMS systems. It integrates seamlessly with other applications on the platform and connects easily with external systems, reducing manual data entry and data reconciliation.

NNIT has accumulated extensive industry experience in the life sciences sector and has provided validation services locally in China to over 100 pharmaceutical companies. Mr. Wu Weiping, Chief Commercial Officer of EClinCloud, said: "NNIT's clinical system validation services are highly professional, and the validation team has a thorough understanding of both domestic and international regulatory requirements for systems. We are also delighted that EClinCloud's CTMS has earned the recognition of the NNIT team, and we look forward to a longer-term partnership."

The product was successfully launched in February 2021. For more information, please contact ecc@eclincloud.com.

About EClinCloud

EClinCloud aims to build a leading clinical trial cloud platform. Guided by the mission of "bringing effective treatments to patients through technological innovation," it is a healthcare and life sciences technology company based in China and serving the world. EClinCloud's clinical research cloud platform is an independently developed, end-to-end, seamlessly integrated unified platform comprising electronic data capture (EDC), randomization and trial supply management (RTSM), electronic clinical outcome assessment (eCOA), clinical trial management system (CTMS), electronic trial master file (eTMF), risk-based monitoring (RBM), and Virtual Trial. Through its specialized solutions, EClinCloud helps pharmaceutical companies, medical device companies, and research institutions accelerate new drug R&D, reduce clinical research costs, and lower clinical research risks.

The company is headquartered in Shenzhen Bay Science and Technology Ecological Park at the heart of the Guangdong-Hong Kong-Macao Greater Bay Area, with an R&D center in Chengdu and branch offices in Beijing and Shanghai. Its founding and management teams bring extensive, longstanding experience in the clinical research field, while its product R&D and operations teams hail from leading internet companies such as Tencent, Huawei, and Alibaba and uphold high standards for platform and software system stability, data security, and process standardization. All software applications on the EClinCloud platform are validated in accordance with the relevant ICH, FDA, and NMPA requirements for clinical research systems and meet the requirements of 21 CFR Part 11.

For more information, please visit: www.eclincloud.com

About NNIT

Headquartered globally in Copenhagen, Denmark, NNIT has focused on the life sciences sector since entering China in 2006, dedicating itself to providing clients with secure, compliant IT services and mature, efficient solutions to help advance their digital transformation. With extensive industry experience, NNIT provides secure, compliant, and tailored IT solution consulting, implementation, validation, and operations and maintenance services across all stages of drug R&D, manufacturing, and commercialization.

Related reading

Cover image for archived article: National Innovation Center adopts EClinCloud CTMS and eTMF systems to digitally enable medical device clinical trialsNews3 min readNational Innovation Center for Advanced Medical Devices Adopts EClinCloud CTMS and eTMF Systems to Digitally Enable Medical Device Clinical TrialsOn October 14, EClinCloud (Shenzhen) Technology Co., Ltd. ("EClinCloud") attended the High-End Medical Device Clinical Trials Symposium and Clinical Trial Project Management System Launch Meeting, hosted by the National Innovation Center for Advanced Medical Devices ("the Center"). At the meeting, EClinCloud CEO Dr. Qin Long introduced the clinical trial project management system.Archived article cover: EClinCloud eTMF system supporting Yuanxin Technology in conducting an international multicenter clinical studyNews3 min readEClinCloud eTMF System Supports Biotyx Medical's International Multicenter Clinical StudyEClinCloud (Shenzhen) Technology Co., Ltd. ("EClinCloud") and Biotyx Medical (Shenzhen) Co., Ltd. ("Biotyx Medical") recently announced a deeper collaboration, under which Biotyx Medical is adopting EClinCloud's eTMF (electronic Trial Master File) solution for its international multicenter clinical trial of a below-the-knee bioresorbable scaffold. Using its digital management platform and extensive experience, EClinCloud supports Biotyx Medical's global business development needs to help it become a globally leading cardiovascular medical device company.Archived article cover: EClinCloud completes tens of millions of RMB in Series A financing to accelerate building its clinical evidence support platformNews3 min readEClinCloud Completes Tens of Millions of RMB in Series A Financing to Accelerate Its Clinical Evidence Support PlatformEClinCloud Technology Co., Ltd. ("EClinCloud") recently announced the completion of tens of millions of RMB in Series A financing, exclusively invested by Kangjun Capital. The proceeds will primarily be used to further strengthen its R&D, medical, clinical operations, and clinical data science teams, accelerate the realization of a patient-centric integrated cloud platform, and enhance after-sales service capabilities.